Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Farmers Insurance
Deloitte
Cerilliant
McKesson
Harvard Business School
McKinsey
Novartis
Covington
Healthtrust

Generated: February 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019959

« Back to Dashboard

NDA 019959 describes NOVOLIN N, which is a drug marketed by Novo Nordisk Inc and is included in two NDAs. It is available from three suppliers. Additional details are available on the NOVOLIN N profile page.

The generic ingredient in NOVOLIN N is insulin susp isophane recombinant human. There are thirty-nine drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the insulin susp isophane recombinant human profile page.
Summary for 019959
Tradename:NOVOLIN N
Applicant:Novo Nordisk Inc
Ingredient:insulin susp isophane recombinant human
Patents:0
Suppliers and Packaging for NDA: 019959
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NOVOLIN N insulin susp isophane recombinant human INJECTABLE;INJECTION 019959 NDA Novo Nordisk 0169-1834 N 0169-1834-11
NOVOLIN N insulin susp isophane recombinant human INJECTABLE;INJECTION 019959 NDA Novo Nordisk 0169-1834 N 0169-1834-02

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:INJECTABLE;INJECTIONStrength100 UNITS/ML
Approval Date:Jul 1, 1991TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Johnson and Johnson
Federal Trade Commission
Cerilliant
Accenture
Deloitte
Daiichi Sankyo
Chubb
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot